Illia Terpylo

Science Writer

Science writer with dual master’s training in bioinformatics (University of Potsdam; Taras Shevchenko National University of Kyiv), focus on computational biology and NGS analysis.

Contributing Author

Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

Latest articles from Illia

Healx Expands Rare Oncology Pipeline Through AI-centered Deal with Vuja De Sciences

Healx, a drug discovery company founded by Tim Guilliams, a Cambridge-trained tech entrepreneur, and David Brown, the co-inventor of Viagra, has entered into a strategic collaboration with Vuja De Sciences to integrate Vuja’s cancer expertise with their Healx’s platform. …

Stanford–Arc Team Reports AI-Made Viruses That Kill Bacteria

Researchers at Stanford University and the Arc Institute report they used a genome-scale generative model to design novel variants of bacteriophage phiX174; 16 of 302 AI-proposed genomes replicated in E. coli and lysed bacteria, indicating functional “AI-written” viruses suitable for …

Causaly Introduces Agentic Research AI Platform For Life Sciences R&D

Causaly has announced Causaly Agentic Research, a new AI platform designed to support life sciences R&D with domain-specific “agentic” AI. The system aims to outperform literature review tools and general-purpose AI by combining internal and external biomedical data with …

Google’s AI Auto-Writes Reproducible Research Software for Genomics and COVID Forecasting

Google Research introduced a Gemini-based system that writes and iteratively improves “empirical software,” with a preprint and an interactive site showing full solution trees. The system treats well-defined scientific problems as scorable tasks and targets a single objective metric, reporting …

LatchBio Publishes 25-Million-Cell Open-Source Spatial Transcriptomics Atlas

LatchBio has released a human spatial transcriptomics atlas of 25 million cells. Covering 45 tissue types, 63 diseases, and data from 11 major platforms (10X Genomics, Bruker CosMx, STOmics Stereo-seq, Vizgen MERSCOPE, Takara Bio Seeker, AtlasXOmics DBiT-seq, Spatial Genomics seqFISH, …